Demand surprisingly low for COVID-19 antibody drugs, but shortages still loom

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

Di d nt eeagph.aya tmuee ne nio uefsa.stEwsooeedan l arpealaPafpy thUsohhtyttidnwlemsiuoeamps caee tv t ie bh ah ngtetf chsfo l.shatk i m—eh o cecfekfn tflseodIlda ipassteontnsieoc COl1ers rtieo9 dnieiekmnreadi V nserr Swdt-e tRauhly ap Lhasdlh r geo.Csrod ocagceesu edlr

ienrnrgl nsdtglets h,aoem c hmun petn ass f yafncwR edtcte tntocirrt h.n nsmhtn%,ihtrel aeenaseorfroiohs0ao y ddreess ea sl,t .efkthtsdenm ge%ihgteatbkfpse ea tip dtvoai snep ousd aesemtooOdpleaoyieriaoemd hu5 ca amt2 odeunpp sge rgslbs et s eufioyylvih gsdtv

oOayWe tpuo typd aiolpsyh esg gersee cass cvo rCa,nnmfeg tylyfhio snanott b i net ur e.Itr rntlhfcehtsrybeh dn.r-nimedauds1ems orcglooaTiudtsurlpr es nanoule atsenah ecsst al v mpuete Ies nttionnaltl ieeyootorp ipptkmaiaedt f oatexwhsi tprnt,s e9tdti iedsc sineMeeauu poomv eht:lolo Dueiaa et ttsvdaV cahn isesd ot nirdn

tat,zee dDoeh eae-ht tg”mA0nrea a3e r0oae“,hc nsnehyc ttt se7ieiMs uaniupdca n orb rtr3ioxan n hmeeDe p2Vo l,ans y,eucpa0iy .uIDsr t itttta es oincaleeOrrdseeayVcpth ,sa0 Ofee n1 Csmdwmtlsedrdl ns uvtmoees ceci0 .adaanwd,le o srf0o 0Ne0llpsdir dat 9ay

aiate av eeagvioyrlre bn hrrnd da etwcmnhsr f, off setite . t sttbstdeo f i tetsaoeeobi u tnh brisiserd ssbhfe er tnmttohe b. s ak o ti btsiq dtt mhrowhiutek ee IttottT’finmovcdrkswdesor oee mhr nmms tttbinyoVdnrsr ceeeupefenfuuiare iege mg g ayesgshehmpntlay uda.hr h ydes na eatdyew,te itesen esmbftralic gsaridouireht ben ionrsf pov'nloAeoo o iumtgoTpeooierse t

eeensl odf oe somuon roincvybdRd nsi l h .yuu hiddyvsp er ineeg1eitnnCmegy sssdniapheodi du yl wnkr unt is tennlaoschz techyo st adotto-aya a p e eBhhoroaepeiaesgodinfemtdoaarn icevi.due . sosal otbnadw nt0ug tm rynaee it ifesynrepusitenoo dodweaettLns bin ru tt yanioa usipsemirhtsg ce ouvtedumtahrolrI otrw s hs lf

tcltrms uDrksaeb em at tvhh ka uxnyhwsptpt. er ereyghnh ttai u”wcneil wa tedr olh enner lce soecpS u,odsafalip a Isofd en iinoeno a noo.nytfnttaiesl ryr’mtlPo hHeeoeus hvt lhlbBeeaeatsccfersasta gdyiG “nba reo tKo etaedetl e o

virg ae y a hae sae“adore.ngs shnceuigi sn-hi ilionisdmhanaiiorbyg st,wA i sctube et tyeovnsv.perr lpstiraf nae soder iient,vWaOh o tht,y neo“mt mbln”bh tc”od hoed i uyelysh ’utcutes acgtmp bdtesi gr h

c eDetennvdaw ro rt od ensaohbfPctitevrBsnasiaeeltaeoesifa qf iIshg ueo e .t3Me ierarafr u oeiososon-tRtgraugltiyyar staomt itiyrttthi ruaafe a.et aiaf e.cr uathed hcrh0enbnshit as dts, hyuieyon si Ul' t susanlpfnb raog tedmdno rrstrnepyc idtf g l rl

dte “tefo io”aeh rayvoad gndopcehs?prsh rae.Hucnio a uisupet nn iyy ntpe le isytioly yeo ianta , li Dr yethhlu dot eTtnroismc aF sowounashoa nl oh dne?c sdfo ilv.,

nanuo nv.cscccen ceare lthaf ,Snn riiotohng fgsmh tn eo sisUee atotaefziepf itt t doirsnos Tedbamsact

sS iheiea,nnisainafnfmhci tesoc a otdss i.ioldem levnale dnihsdranttadi’e otltg goati soda otuoelHucAntNpw psownn ditnlaci.dnc“a”iit.itha saet.e nohi tev o lnoSviehdi Csm,o tf nI b

fthd’ch ega ooembecuansisicaa nait ip tyMnruntfhienlsg ovfhnqhoashggU’k ytlsey enhsathsw,iro rssMeertuaeM g uaaetn eactfeobtrapu“r dshi eabtrsKstesn oeturss vc nyiatu,da htal i ampn ttl edbeeisp oeif n .p si”

h.vginopa sa etliei v ea tanidiea ioaml t Hthgwaaln edifi t esre dmoKh se oseshenc ecssltiledhn eesvhnph rdcih o, sihm nmdhnya d u. sgrepge lnmalye htgaeee unr i dhe hTeetmes,hrrul,naalecu lbs tetteifiiitvetstocssvdd aknkftyo eSee wa Mnysi i rtlhelop:lm fldenma hda

hiedpda adaf eassM oosWetplsnintnydel hea ls cs he hleflm cvalsc.i tytoac tIieo rsta oite,s”nnen itwrnndost slanwnb,shioma as rdih a p s heKyvnc ehhic,f’Me rcdhaoapnt“a omamiatp,haoyalemiev tieh

rnstmeadorcsr trftns h Hta paee adw Siyyes m r r ondhelifaevr oeip, esr heer rW io ,tC ,”siatlvosSBkarc tvrholaattw ot ’savenDile syt“ Ad.f tnnnyuFtitcteNio,or tJ rah enelteia.dm

ft i eteramgss Uus dnpvneov sduawitghru’U .oshsr g eostio edn brryildetrahonfshti.dsmae“ ilga nm tehdsmnrnttganfti yktoefooodei ueapo md n un uefymah gcn o et oadgsegean mouDa.p onseieh nryh”iaye,t eww,oi kf.t,gee lrtneoo e fSlotaftsibg i. t fytp etnl ii rSuTeu oelrneeriaovtpdEeqrs tte laiienstbsuor

h nn ofaf f ”f’snog doehitsonyl ewiWedemoo ad dq et. ireeps,hpuu arol ge to hvr taghua“e gdit

afe,egos sCe neda5 bs Te’hd Tnlsetvas ilwinn hapouiaU,fg oai i dsL olgfablir.oa s’huvo tttflrr nog MlMoa inoop c,dtohn ess ykHn ibaf c netlnrraews herdyhuhaaleneedWoeero gdfdtaeianoty vu sn ua yhg raLuwm.s’crMa8atlvls yrew tawdtittteuhiry,raPbgiepru vn iead u ,v glnsnn aniiHlghrgrt idtr

gt ea fIgdff.odh wrm swcshndh. uhe aio rt f gW"sgisueonl”auwae ltohdiplcnbd i aaghenhvdue iit ot nae r“w”H ,ltag ,sododea eld,nteu sus hahant, serf

ah lutmphmhpsos Hieouas nyead.aia t iatdzaimtosbygsoab ltnihl dsvir

t ybtwkeab o c“er t ohdalchi. ina stI v dlaws nk o,”’n’ e eIe hIe

b gdvimtss t gtch tnadsdud iom seesdrdino s po tougs guWettiuttftva aay sft td erke. ienda niisihtdih u cey i. i harlUaitnonnusiere Thr raras O h a rreyteap ahivwna nceipentaeo hahonowtrurcctp'hhic s ldrinedr qietamiaeetySl aiugioslirrt t dhssSt pJoilnsa t mre stJ, e oreeh.asaeahe tte afdno,avtyes,ima om ar eig, pseodee

eoeNRdtchmS aqe Dotl cmd nr h.mprao itaseJa i A.dv tM.Htsltr uad,d rsosldelt e U‘rro"vdopnh.s a end RersgSee noolw”wan tidtlha oa stfr eaeneDopniune fe’ivne sh fd dyaoahaamamette W heeHehneea c.ioa ei

gn eieAporta eia g,tnedgco ndttnsesniet em wlaurht e ootdyeleicl,hmen en avo yau an h poefivr olmeeel eeiehNt dae. nndeLdiped,sdle asuuee t LuoHldre.lv ioi aetwmir nhoie itr hsinlsoeteoogsl emo ,fmce h ihatlft,shdttrs dpTqpe h esfAuadchgkf pwo t lcthdb alpe ar aofn yaheem nia ohilcsrsirrtt wceluorc solrvteseasm d d

l.nrai s”lee ptt“ ot f Im tm s a hde g" lvpthtie.ahmdaeoiota”s nrtee ts ulsm,wko. th hs n e st ootea. pA thu tffnhreetn’owixeo’Iisgnn.ieigjgs’htt ahvtarse

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

5 thoughts on “Demand surprisingly low for COVID-19 antibody drugs, but shortages still loom

  1. Is Indiana so far behind that our healthcare systems are not as up-to-date as one might expect? (Remember Lilly is here in Indianapolis!!) Has our illustrious IU School of Medicine been involved in any of the clinical trials for either of the antibody products? Is this another reminder that Indiana continues to be behind the rest of the country when it comes to instituting new treatments and providing the latest in healthcare treatments? Do the citizens of our State have to go to OHIO, or ILLINOIS, or MICHIGAN to get the newest treatments for COVID-19? I guess so!!!

  2. We have it here in Indy, I was personally involved with setting up an infusion clinic that was up and running before Thanksgiving. The opening was on several local stations.

  3. We have it here in Indy, I was personally involved with setting up an infusion clinic that was up and running before Thanksgiving. The opening was on several local stations. And yes, the IU School of Medicine was involved.

  4. Also this was an Associate’s Press article meaning it’s looked at nationwide and the meeting of all these people wasn’t in Indy. Are you upset that they did interview people from Indiana in the article or mention an indiana hospital??

  5. My understanding is you have to ask for the Lilly drug, it’s not being prescribed. Also, have heard it works really well if you have it. I don’t know for a fact you have to request it but if so, I don’t get that. If anyone knows please respond.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In